APSF News & Updates
New Factor Xa Inhibitor (Xarelto®) (Eliquis®) Reversal Agent
August 5, 2018 -The first Factor Xa inhibitor reversal agent, andexanet alfa (brand name of AndexXa®) received FDA approval in early May 2018. Aandexanet alfa is indicated for patients who have been treated…
APSF Fire Safety Video Contributes to 44% Decrease in Intraoperative Fires Since 2011
July 5, 2018 -The Anesthesia Patient Safety Foundation (APSF) is pleased to announce the ECRI Institute (Emergency Care Research Institute) and the Pennsylvania Patient Safety Authority (PSA) have updated the statistics on surgical…
Anesthesiology Foundations Announce $300,000 Patient Safety Grant for Early Stage Investigators
June 7, 2018 -Applications Open June 7 CHICAGO – The Anesthesia Patient Safety Foundation (APSF) and Foundation for Anesthesia Education and Research (FAER), charitable arms of the American Society of Anesthesiologists (ASA), today…
APSF Safety Recognition Award Best Practices for Safe Medication Administration during Anesthesia Care
March 30, 2018 -APSF Safety Recognition Award Best Practices for Safe Medication Administration during Anesthesia Care Sponsored by the APSF Committee on Technology Deadline for Submission: June 15, 2018 The Anesthesia Patient Safety…
